|
Fredun Pharmaceuticals Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
475.40 Cr.
|
P/BV
|
3.63
|
Book Value (Rs.)
|
277.17
|
|
52 Week High/Low (Rs.)
|
1020/635
|
FV/ML
|
10/1
|
P/E(X)
|
22.85
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
44.07
|
Div Yield (%)
|
0.07
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 119.40 | 165.44 | 0.00 |
| Total Income From Operations | 119.40 | 165.44 | 0.00 |
| | | | |
| EXPENDITURE | | | |
| Consumption of Raw Materials | 91.08 | 125.01 | 0.00 |
| Increase/Decrease in Stocks | -6.66 | -1.23 | 0.00 |
| Employees Cost | 7.63 | 9.70 | 0.00 |
| Depreciation | 1.42 | 1.84 | 0.00 |
| Other Expenses | 10.81 | 16.68 | 0.00 |
| Total Expenses | 104.28 | 152.00 | 0.00 |
| | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 15.12 | 13.44 | 0.00 |
| Other Income | 0.45 | 1.97 | 0.00 |
| P/L Before Interest, Excpt. Items & Tax | 15.57 | 15.41 | 0.00 |
| Interest | 6.53 | 8.15 | 0.00 |
| P/L Before Exceptional Items & Tax | 9.04 | 7.26 | 0.00 |
| P/L Before Tax | 9.04 | 7.26 | 0.00 |
| Tax | 2.27 | 1.26 | 0.00 |
| P/L After Tax from Ordinary Activities | 6.77 | 6.00 | 0.00 |
| Net Profit/Loss For the Period | 6.77 | 6.00 | 0.00 |
| Net P/L After Minority Interest & Share Of Associates | 6.77 | 6.00 | 0.00 |
| | | | |
| Equity Share Capital | 4.72 | 4.72 | 4.72 |
| EPS Before Extra Ordinary * | | | |
| Basic EPS (Rs.) | 14.33 | 12.71 | 0.00 |
| Diluted EPS (Rs.) | 14.33 | 12.71 | 0.00 |
| EPS After Extra Ordinary * | | | |
| Basic EPS (Rs.) | 14.33 | 12.71 | 0.00 |
| Diluted EPS (Rs.) | 14.33 | 12.71 | 0.00 |
| | | | |
| PBITOE Margin (%) | 12.66 | 8.12 | N.A |
| PBTE Margin (%) | 7.57 | 4.39 | N.A |
| PBT Margin (%) | 7.57 | 4.39 | N.A |
| PAT Margin (%) | 5.66 | 3.62 | N.A |
| PAT After MI And SOA Margin (%) | 5.66 | 3.62 | 0.00 |
